Here’s how much $5,000 invested on Monday in marijuana stock Stemcell Utd Ltd would be worth today

It’s the company that’s gone gangbusters on the coronation of the “Cannabis King” as it’s official adviser and it’s likely to have made some lucky investors rather rich.

Earlier in March the Stemcell Utd Ltd (ASX: SCU) share price was trading at around 1.3 cents per share, but closed today at 37 cents per share on traders’ excitement over little more than its fast-rising share price.

In fact the Stemcell Utd share price hit a high of $1.08 today on a market value of more than $300 million in a scenario that can only be attributed to some wild trading that would have kept many speculators glued to their screens.

The sum of $5,000 invested in Stemcell shares at 1.3 cents per share in early March would have earned you 384,615 shares worth around $142,307 at the close of trade today, or nearly $400,000 if you had managed to sell at the top of today’s trade.

There’s no doubt that those are some impressive returns, but in truth your chances of striking it rich on a penny stock are only slightly better than your chances of being struck by lightning twice – on the same day.

For that reason I would suggest you ignore the fortune-losing penny stocks to focus on stocks where you can make a real world fortune.

So forget the pot stocks and focus on high-quality profitable businesses with long track records, as it’s not hard to make serious money in the stock market as long as you let time do the heavy lifting.

So why not look to healthcare companies that are the real deal when it comes to creating retirement-making fortunes?

Such as CSL Limited (ASX: CSL) or Cochlear Limited (ASX: RHC). Both have delivered giant capital gains while paying dividends over the past 10 years. And I expect they have plenty of room to run in the decade ahead.

Another company that could offer BLOCKBUSTER returns over the long term is our #1 dividend pick for 2017....

With its shares up 155% in just the last five years, this 'under the radar' consumer favourite is both a hot growth stock AND our expert's #1 dividend pick for 2017. Now we're pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is click the link below!

Simply click here to receive your copy of our brand-new FREE report, "The Motley Fool's Top Dividend Stock for 2017."

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. and CSL Ltd.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.